Table 1.
Demographics and key characteristics of the in vivo population
| Young CN individuals | Elderly CN individuals | MCI patients | AD patients | |
|---|---|---|---|---|
| N | 3 | 6 | 3 | 4 |
| Age (years), mean (SD) | 22.3 (1.5) | 67.8 (8.5) | 69 (3.4) | 60.7 (6) |
| Male, n (%) | 2 (67) | 5 (83) | 2 (67) | 3 (75) |
| MMSE, mean (SD) | 30 (0) | 29.5 (0.5) | 25 (2.6) | 17.3 (5.8) |
| APOE ε4, n (%) | 0 (0) | 4 (67) | 1 (33) | 2 (50) |
| Amyloid-PET positive, n (%) | 0 (0) | 1 (17) | 3 (100) | 4 (100) |
AD Alzheimer’s disease, CN cognitively healthy, MCI mild cognitive impairment, MMSE Mini-Mental State Examination, PET positron emission tomography, SD standard deviation